Most Recent
Railway technology company Wavetrain Systems has dropped its bid for a court order barring a competitor started by its former CEO from making allegedly false claims about its patented rail safety devices to clients.
The Full Court has denied a request by Sanofi that it review a judge's refusal to block Alphapharm from listing its Semglee insulin injector pen on the PBS, calling the pharmaceutical giant's appeal "misconceived".
New Zealand-based medical device maker Fisher & Paykel and US-based ResMed have agreed to resolve all disputes between them over patents for devices used to treat sleep apnea.
Property listing rivals REA Group and Domain have settled a trade mark lawsuit over an agreement between Domain and the owner of US website realestate.com to redirect Australian traffic to Domain's website.
Maurice Blackburn has persuaded a judge to lift a temporary injunction that blocked the law firm from going ahead with plans to unveil a replica of the iconic New York statue, Fearless Girl, at Melbourne's Federation Square for International Women's Day.
The Full Federal Court will issue its judgment Friday in French pharmaceutical giant Sanofi's challenge to a judge's refusal to block Alphapharm from listing an insulin injector pen on the PBS, just two weeks after the court heard arguments in the appeal.
Generic drug maker Sandoz must pay $26.34 million to Danish pharmacuetical giant Lundbeck and a subsidiary for infringing the Australian patent behind the blockbuster antidepressant Lexapro, a judge has found.
Drug maker Neurim Pharmaceuticals has won a bid to amend its Australian patent for top selling sleeping pill Circadin over the protests of two generic pharmaceutical companies, whch argued Neurim had purposely delayed the application to gain an unfair advantage in its infringement suit.
Pharmaceutical giant Allergan has streamlined its trade mark case against Self Care Corporation, which makes products marketed as Botox alternatives.
Canadian generic manufacturer Apotex has agreed to drop its lawsuit against India's Cipla seeking to invalidate its Australian patent for popular nasal spray Dymista.